272 filings
8-K
AADI
Aadi Bioscience Inc
11 Dec 20
Aerpio Announces Statistically Significant Topline Results from
5:08pm
4
OrbiMed Capital GP V LLC
10 Dec 20
Change in insider ownership
5:04pm
SC 13D/A
AADI
Aadi Bioscience Inc
23 Nov 20
Aerpio Pharmaceuticals / Satter Muneer A ownership change
12:00am
SC 13D/A
AADI
Aadi Bioscience Inc
12 Nov 20
Aerpio Pharmaceuticals / ORBIMED ADVISORS ownership change
5:15pm
10-Q
2020 Q3
AADI
Aadi Bioscience Inc
Quarterly report
10 Nov 20
8:32am
8-K
c52boc u82hhp6
10 Nov 20
Aerpio Reports Third Quarter 2020 Financial Results and Provides Business Update
8:11am
424B5
xaxa fen26
25 Sep 20
Prospectus supplement for primary offering
4:11pm
8-K
78465dvxnaxp
12 Aug 20
Aerpio Reports Second Quarter 2020 Financial Results and Provides
8:11am
424B5
yczt972rgzzxnbn
5 Aug 20
Prospectus supplement for primary offering
7:30am
8-K
aif924 md
5 Aug 20
Regulation FD Disclosure
7:23am
4
tzbgyixlhj3z8cbtzp9
26 Jun 20
Aerpio Pharmaceuticals / Pravin Dugel ownership change
4:44pm
4
rmeyc
26 Jun 20
Aerpio Pharmaceuticals / Anupam Dalal ownership change
4:43pm
4
6ya87n5
26 Jun 20
Aerpio Pharmaceuticals / Caley Castelein ownership change
4:42pm
4
w2fa1 9p5hp
26 Jun 20
Aerpio Pharmaceuticals / Steven Prelack ownership change
4:42pm
4
kbca4
26 Jun 20
Aerpio Pharmaceuticals / Cheryl Cohen ownership change
4:40pm
8-K
n8x6syw ky5if81kjp
25 Jun 20
Aerpio Announces Initiation of28-Day Phase 2 Razuprotafib Glaucoma Trial
8:56am
DEFA14A
vwwzggop nj207
8 Jun 20
Additional proxy soliciting materials
5:05pm
8-K
t034qs6s5gcmvhhm
28 May 20
Regulation FD Disclosure
9:12am
SC 13D/A
2xhz64xpqf 7ke45879j
15 May 20
Aerpio Pharmaceuticals / Novartis Bioventures ownership change
6:05am